scholarly article | Q13442814 |
P356 | DOI | 10.1016/0024-3205(92)90440-Z |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:002432059290440Z?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:002432059290440Z?httpAccept=text/xml | ||
P698 | PubMed publication ID | 1732708 |
P2093 | author name string | D. R. Sibley | |
Monsma FJ Jr | |||
I. Creese | |||
S. X. Xu | |||
F. J. Monsma | |||
P2860 | cites work | Molecular cloning and expression of the gene for a human D1 dopamine receptor | Q24298197 |
Cloning and expression of human and rat D1 dopamine receptors | Q24306738 | ||
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 | Q28258672 | ||
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes | Q34272920 | ||
Multiple D2 dopamine receptors produced by alternative RNA splicing | Q35164518 | ||
Multiple receptors for dopamine | Q37876912 | ||
A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus | Q38342286 | ||
Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding | Q39268993 | ||
The Classification of Dopamine Receptors: Relationship to Radioligand Binding | Q40114495 | ||
Receptor Adaptations to Centrally Acting Drugs | Q40124746 | ||
Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site | Q41744150 | ||
Regulation of the glial fibrillary acidic protein, beta actin and prion protein mRNAs during brain development in mouse | Q43723035 | ||
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level | Q44598589 | ||
Purification and cloning of a mouse ribosomal gene fragment in coliphage lambda | Q44633859 | ||
Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade | Q44725929 | ||
Histone gene expression during sea urchin embryogenesis: Isolation and characterization of early and late messenger RNAs ofStrongylocentrotus purpuratus by gene-specific hybridization and template activity | Q45090471 | ||
Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivation | Q48122646 | ||
Ontogenesis of dopamine receptor binding in the corpus striatum of the rat | Q48299512 | ||
Denervation accelerates the reappearance of neostriatal D-2 receptors after irreversible receptor blockade | Q48508930 | ||
Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. | Q48521950 | ||
Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study | Q48706395 | ||
Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment | Q48895828 | ||
Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. | Q52245232 | ||
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. | Q55058608 | ||
Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain | Q67679491 | ||
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour | Q68082556 | ||
Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats | Q68163104 | ||
Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen | Q68440218 | ||
Quantitative autoradiographical analysis of the age-related modulation of central dopamine D1 and D2 receptors | Q68564846 | ||
Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary | Q69378141 | ||
Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats | Q69863619 | ||
Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms | Q70028400 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 383-396 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | Life Sciences | Q5256275 |
P1476 | title | Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment | |
P478 | volume | 50 |
Q48502124 | Antipsychotic regulation of dopamine D1, D2 and D3 receptor mRNA. |
Q48653355 | Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression |
Q73215710 | Brain dopamine D2 receptor mRNA levels are elevated in young spontaneously hypertensive rats |
Q40206258 | Brain-derived neurotrophic factor regulates the expression of D1 dopamine receptors |
Q48678048 | Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis |
Q33739069 | Effect of betamethasone on the expression of dopamine D1 receptor mRNA in the developing rabbit adrenal gland |
Q35165425 | Is there a subtype of developmental Parkinson's disease? |
Q48591151 | Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors |
Q40621162 | New concepts in dopamine receptor plasticity |
Q48174497 | The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain |
Search more.